CXCL13 and Miyoshi myopathy: Furthermore, CXCL13 silencing using CRISPR editing in MM cells suppressed MM growth in the BM niche in vivo and significantly reduced the expression of osteoclastogenic markers and trabecular bone destruction in the BM of mice inoculated with CXCL13-depleted MM cells.